Related Articles
Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas
Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma
Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis
Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis
Absence of therapeutically relevant c-erbB-2 expression in human hepatocellular carcinomas